
Jonathan Kaufman, MD
@jkaufmanmd
Myeloma/amyloid/plasma cell doctor @WinshipAtEmory #myeloma. #mmsm
ID: 4352079742
https://winshipcancer.emory.edu/multiple-myeloma 02-12-2015 15:53:47
776 Tweet
2,2K Followers
88 Following

NEXT MONTH! 🗓️ Join us on May 20th at the #MyelomaRoundTable with top speacialists @stuchman1 Cristina Gasparetto Urvi Shah Jonathan Kaufman, MD Sasha E. Knowlton, M.D. in Raleigh-Durham, NC. More information here: buff.ly/3om0yF6 #HealthTreeMM #myeloma #multiplemyeloma #mmsm


📣We look forward to welcoming you at the 9th COMy Congress! The congress platform is open!⬇️ comylive.cme-congresses.com Starting May 11 8:30 CEST HOW TO ACCESS? Link to the Lecture Hall⬇️ comylive.cme-congresses.com/lecture-hall/ Log in using the email address you registered with. Mohamad Mohty


The Tao of Myeloma Progression by Paola Neri. Brilliant talk as always. COMy nizar jacques bahlis Mohamad Mohty



It was a pleasure to speak with Jonathan Kaufman, MD today at #COMy23, who discussed treatment approaches for elderly/frail patients with myeloma & updates with modakafusp alfa in this disease. Check out some of our interviews on vjhemonc.com! #MMsm



Important work led by Ajay Nooka, MD, MPH

Great to see excellent presentation from the new generation of #mmsm stars at #IMWGsummit23! Dr. Nisha Joseph Winship Cancer Institute of Emory University presents on strategies for newly diagnosed myeloma. Benefit for Dara in 1L more clear. What about carfilzomib vs velcade combo in high risk?




I’m excited to co-chair the upcoming Innovations in Cancer Care Summit alongside Jonathan Kaufman, MD and the rest of our Winship Cancer Institute of Emory University Faculty as part of the AJMC Institute of Value Based Medicine Join us in person July 25th as our faculty experts discuss some of the most


Emory group does it again! Important JCO Oncology Practice #MMsm research: Black race an in independent predictor of bortezomib-related neuropathy (46% vs 34%) despite similar sex, DM, etc. Important to take symptoms seriously, dose reduce prn, and eschew twice-weekly Velcade! Kathryn Maples, PharmD




Brilliant analysis by Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 This is the key point. Without an approval, we are not able to do these studies.

Bendamustine va Fludarabine/cyclophosphamide as lymphodepletion prior to BCMA CAR-T in myeloma #mmsm #cartsm Our two center experience Murali Janakiram nature.com/articles/s4140…


Excited to share our experience with prophylactic tocilizumab for prevention of teclistamab associated CRS! Ellen Marin Blood Cancer Journal nature.com/articles/s4140…

Winship Cancer Institute of Emory University Sagar Lonial MD Jonathan Kaufman, MD the honor to have a drink from that king glass at Sagar home happens when you hit an important career mile stone. Congratulations my friend - you are an associate professor
